What is Lumenis?
Lumenis Ltd. is a pioneering company specializing in the development and commercialization of advanced energy-based technologies tailored for skin, body, and eye care treatments. Established in 1966 and headquartered in Hesse, Germany, the company offers a diverse portfolio of innovative solutions, including its well-regarded trilift, optilight, stellar M22, optiplus, and digital duet systems. These technologies are designed to address a wide range of medical and aesthetic needs, positioning Lumenis as a key innovator in the global medical device market.
How much funding has Lumenis raised?
Lumenis has raised a total of $195M across 2 funding rounds:
Private Equity
$120M
Stock Offering
$75M
Private Equity (2006): $120M with participation from XT Group
Stock Issuance/Offering (2014): $75M, investors not publicly disclosed
Key Investors in Lumenis
XT Group
XT Group is a global holding company with diverse interests, including shipping and high-tech ventures. Their investment in Lumenis suggests a strategic focus on expanding their portfolio within the healthcare technology sector, leveraging their experience in managing complex, market-leading subsidiaries.
What's next for Lumenis?
The recent major strategic investment in Lumenis signals a pivotal moment for the company, likely enabling accelerated expansion of its product development pipeline and market penetration. With a history of significant capital raises, including a substantial stock issuance in 2014 and prior private equity backing, Lumenis is well-positioned to leverage this new financing for further innovation and global reach. This infusion of capital is expected to fuel advancements in energy-based medical technologies, reinforcing Lumenis's commitment to enhancing patient care and aesthetic outcomes worldwide.
See full Lumenis company page
